BioSpace News Archive

Unum Therapeutics Inc. today announced plans to prioritize resources towards advancing its preclinical program, BOXR1030, for the treatment of solid tumor cancers.

ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management solutions today announced that a leading biopharmaceutical company in the U.S., has chosen ValGenesis’s cloud-based, 100% paperless Validation Lifecycle Management System (VLMS), to digitalize computer system validation processes across their organization

Trinity Life Sciences, a global leader in life sciences solutions, announced it continues to see inflective growth in its Health Economics and Outcomes Research services.

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, released an update today regarding its pre-clinical studies held at the company’s High Throughput Screening (HTS) facility in Israel.

Todos today announced the publication of data from a human clinical study in the scientific journal Analytical Chemistry.

Bactiguard Holding AB (publ) (“Bactiguard”) has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), which was announced on 4 February 2020 .

The award recognizes Monteris Medical founders Mark G. Torchia and Richard Tyc for the development of the minimally invasive NeuroBlate® System

The Conrad N. Hilton Foundation will invest USD $500,000 to support the sight-saving work Orbis International carries out on its Flying Eye Hospital, the world’s only fully accredited ophthalmic teaching hospital on board an MD-10 aircraft..

AliveCor, the leader in AI-based, personal ECG technology, and provider of enterprise cardiology solutions, today announced the appointment of Siva Somayajula, as its Chief Technology Officer.

The National Kidney Foundation is joining forces with the U.S. Department of Health and Human Services, the American Society of Nephrology, and actor Wilmer Valderrama to reach the 1 in 3 American adults at risk for kidney disease.